451 completed, 110 unknown, 87 recruiting, 63 not yet recruiting. 322 Not applicable, 95 Phase 4, 88 Phase 3, 77 Phase 2, 61 Phase 1.
Follow Prostatic Hyperplasia: new trials by email Literature Review of Prostatic Hyperplasia trials Research Report on Prostatic Hyperplasia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| RELEASE Ph2 RT-310 BPH Study RT-310 PK, Placebo, RT-310 - Benign Prostatic Hyperplasia (BPH) | Phase 2 | Not yet recruiting | Resurge Therapeutics Inc. | 86 | 2027-01-01 | 2026-11-10 |
| Ceasing Alpha-blockers Early After Resection of the Prostate (The CLEAR Trial) Tamsulosin hydrochloride 0.2 mg, Placebo - Benign Prostatic Hyperplasia | Phase 4 | Not yet recruiting | Shanghai East Hospital | 400 | 2026-12-01 | 2026-09-29 |
| Anterior Bridge-Preserving Versus Conventional Early Apical Release in Bipolar Enucleation of the Prostate Anterior Bridge-Preserving Semicircular Early Apical Release (ABP-S-EAR), Conventional Early Apical Release (EAR) - Benign Prostatic Hyperplasia, Benign Prostatic Obstruction | Not applicable | Not yet recruiting | Benha University | 230 | 2026-11-30 | 2026-10-26 |
| Anterior Bridge-Preserving Versus Conventional Early Apical Release During Holmium Laser Enucleation of the Prostate Anterior Bridge-Preserving Semicircular Early Apical Release (ABP-S-EAR), Conventional Early Apical Release (EAR) - Benign Prostatic Hyperplasia, Benign Prostatic Obstruction | Not applicable | Not yet recruiting | Ahmed Ebrahim Zahran | 230 | 2026-11-30 | 2026-10-23 |
| A Study to Track the Safety of Vesomni in Men in South Korea Treated in Routine Clinical Practice for the Urinary Symptoms of Benign Prostatic Hyperplasia (Enlarged Prostate) Vesomni - Benign Prostatic Hyperplasia | Not yet recruiting | Astellas Pharma Korea, Inc. | 600 | 2026-11-30 | 2026-10-15 | |
| Efficacy and Safety of Combination Therapy Compared With Monotherapy in Patients With Benign Prostatic Hyperplasia Finasteride 5 mg Tablet, single dose, Tamsulosin 0.4Mg Capsule - Benign Prostatic Hyperplasia | Phase 3 | Not yet recruiting | Il-Yang Pharm. Co., Ltd. | 660 | 2026-11-09 | 2026-10-13 |
| Modified SOLTIVE Study SOLTIVE Premium SuperPulsed Laser System - Calculi, Renal, Calculi, Urinary | Not yet recruiting | Olympus Corporation of the Americas | 250 | 2026-11-01 | 2026-10-05 | |
| The FLOW Registry. Benign Prostatic Hyperplasia (BPH) | Not yet recruiting | University of Chicago | 3000 | 2026-11-01 | 2026-10-21 | |
| Prostatic Artery Embolization Using Histoacryl as a Novel Embolizing Agent for Treatment of BPH Prostatic Artery Embolization with N-butyl Cyanoacrylate - Benign Prostatic Hyperplasia, Lower Urinary Tract Symptoms | Not applicable | Not yet recruiting | Assiut University | 30 | 2026-11-01 | 2026-10-29 |
| To Establish the Safety and Effectiveness of the ALPFA GRAIL PFA System for Treating Symptomatic Benign Prostate Hyperplasia (BPH) Also Known as an Enlarged Prostate. Treatment Device: The ALPFA Medical (ALPFA) GRAIL™ Pulsed Field Ablation (PFA) System, Control Device: Sham flexible cystoscopy - Benign Prostatic Hyperplasia (BPH) | Not applicable | Recruiting | ALPFA Medical | 250 | 2026-10-28 | 2026-11-12 |
| Perioperative Dutasteride for Hemorrhage Control in Bipolar TURP Under Anticoagulation. Dutasteride (0.5mg), Placebo - Benign Prostatic Hyperplasia, Postoperative Hemorrhage | Phase 4 | Not yet recruiting | Mohamed Mahmoud Dogha | 44 | 2026-10-21 | 2026-11-02 |
| Evaluation of the Aulea Veloxion™ Disposable Resectoscope System for Operational Efficiency in Surgical Management of Benign Prostatic Hyperplasia (BPH) TURP using the Aulea Veloxion™ Disposable Resectoscope System, Aulea Veloxion™ Disposable Resectoscope System - BPH (Benign Prostatic Hyperplasia) | Not applicable | Recruiting | Chinese University of Hong Kong | 20 | 2026-10-02 | 2026-10-27 |
| Orientation Video Training Administered at Different Times to Patients Undergoing Prostate Surgery on Postoperative Pain and Anxiety (Video Training) Operating Room Orientation Video Education, Routine Preoperative Information - Benign Prostate Hypertrophy(BPH) | Not applicable | Not yet recruiting | Ondokuz Mayıs University | 126 | 2026-10-01 | 2026-10-16 |
| Ultrasound-Guided vs. Conventional Prostate Suspension in BPH: An Exploratory Study Ultrasound-Guided Prostatic Urethral Lift, Conventional Prostatic Urethral Lift - Benign Prostatic Hyperplasia | Not applicable | Not yet recruiting | Shanghai East Hospital | 20 | 2026-10-01 | 2026-10-14 |
| ProVIDE Studies Post Exit Analysis ProVee Urethral Expander System - BPH With Symptomatic Lower Urinary Tract Symptoms | Recruiting | ProVerum Medical | 25 | 2026-09-30 | 2026-11-05 | |
| HoLEP-ThuLEP - Comparing Lasers for BPH Surgery Thulium Laser Enucleation of the Prostate (ThuLEP), Holmium Laser Enucleation of the Prostate (HoLEP) - BPH (Benign Prostatic Hyperplasia) | Not applicable | Recruiting | Ludwig-Maximilians - University of Munich | 150 | 2026-09-05 | 2026-10-07 |
| Prospective Post Market Clinical Trial for the Zenflow Spring System - A Minimally Invasive Treatment for LUTS Associated With BPH. Zenflow Arm: Zenflow Spring System implant procedure, Medical Therapy Tamsulosin - Benign Prostatic Hyperplasia (BPH), Obstructive Lower Urinary Tract Symptoms (LUTS) | Phase 4 | Not yet recruiting | Zenflow, Inc. | 110 | 2026-09-01 | 2026-09-01 |
| Vivifi Device Safety Evaluation for the Treatment of Benign Prostatic Hyperplasia Minimally invasive percutaneous ablation - Benign Prostatic Hyperplasia | Not applicable | Not yet recruiting | Vivifi Medical | 20 | 2026-09-01 | 2026-08-04 |
| Study of Teverelix DP on Prostate Volume, Urinary Function and Clinical Outcomes Following Acute Urinary Retention Teverelix DP, Teverelix DP Placebo - Acute Urinary Retention, Benign Prostate Hypertrophy(BPH) | Phase 2 | Not yet recruiting | Antev Ltd. | 126 | 2026-09-01 | 2026-07-29 |
| Irreversible Electroporation (IRE) for the Treatment of Lower Urinary Tract Symptoms (LUTS) in Men With Benign Prostatic Hyperplasia (BPH) Irreversible Electroporation - Lower Urinary Tract Symptoms (LUTS) in Men With Benign Prostatic Hyperplasia (BPH) | Not applicable | Not yet recruiting | Angiodynamics, Inc. | 40 | 2026-09-01 | 2026-06-11 |
Showing 20 of 812. Sign in to see all of them.
Lower Urinary Tract Symptoms (149) · Prostatic Neoplasms (60) · Urinary Bladder, Overactive (23) · Urinary Bladder Neck Obstruction (21) · Erectile Dysfunction (20) · Urinary Retention (19) · Urinary Incontinence (15) · Urinary Bladder Neoplasms (14) · Prostatic Diseases (13) · Hyperplasia (10) · Kidney Calculi (8) · Nocturia (8) · Urinary Incontinence, Stress (8) · Urinary Tract Infections (8)
Urogenital Diseases (812) · Genital Diseases (811) · Male Urogenital Diseases (809) · Genital Diseases, Male (808) · Prostatic Diseases (799) · Pathological Conditions, Signs and Symptoms (225) · Signs and Symptoms (197) · Urological Manifestations (187) · Female Urogenital Diseases (108) · Female Urogenital Diseases and Pregnancy Complications (108) · Urologic Diseases (105) · Neoplasms by Site (76) · Neoplasms (74) · Urogenital Neoplasms (72) · Genital Neoplasms, Male (60)
Tamsulosin (85) · Dutasteride (46) · Transurethral Resection of Prostate (38) · Tadalafil (33) · Finasteride (21) · silodosin (20) · alfuzosin (17) · Solifenacin Succinate (13) · Botulinum Toxins, Type A (10) · Adrenergic alpha-Antagonists (9) · 5-alpha Reductase Inhibitors (7) · Doxazosin (7) · Saline Solution (6) · Therapeutics (6) · mirabegron (6)
GlaxoSmithKline (43) · Boehringer Ingelheim (18) · Eli Lilly and Company (17) · Mansoura University (15) · Ain Shams University (12) · Chinese University of Hong Kong (12) · Samsung Medical Center (12) · Beni-Suef University (11) · Sanofi (11) · Assiut University (10) · Benha University (10) · Boston Scientific Corporation (10) · Northwestern University (10) · PROCEPT BioRobotics (9) · NeoTract, Inc. (8)
United States (186) · Egypt (76) · South Korea (69) · France (59) · Canada (53) · China (51) · Italy (43) · Turkey (Türkiye) (37) · Germany (32) · Spain (28) · United Kingdom (26) · Taiwan (24) · Australia (19) · Netherlands (18) · Hong Kong (17)
Ahmed M Elshal, MD (4) · Chi Fai NG, MD (4) · Kyu-Sung Lee, Ph.D (4) · Amy E Krambeck, MD (3) · Bilal Chughtai, MD (3) · Claus Roehrborn, MD (3) · Donald Neff (3) · Hazem Elmansy, MD (3)
PMID 26299520, PMID 24972732, PMID 25613154, PMID 29873008, PMID 30677455, PMID 42265447, PMID 12559262, PMID 21135869, PMID 21420124, PMID 21475707, PMID 21538499, PMID 21791356, PMID 21944127, PMID 23098762, PMID 23234617, PMID 24502959, PMID 25937539, PMID 26283011, PMID 28800206, PMID 28801563, PMID 30721737, PMID 32868137, PMID 33872051, PMID 34532768, PMID 36273485, PMID 10367836, PMID 10492184, PMID 10675166, PMID 11056488, PMID 11096237, PMID 11111208, PMID 11590294, PMID 11786675, PMID 11796283, PMID 11832306, PMID 12121722, PMID 12361895, PMID 12648190, PMID 12689743, PMID 1279218, PMID 12796668, PMID 12818001, PMID 12837423, PMID 12893330, PMID 14499682, PMID 14681504, PMID 15126771, PMID 15227649, PMID 15865523, PMID 15867530
2008 (2), 2018 (2), U01DK060817 (2), 2014 (1), 2015 (1), 2025 (1), K12DK111028 (1), P30CA012197 (1), R01DK056199 (1), R01DK124502 (1), R01DK135516 (1), R01DK135804 (1), R01DK142211 (1), R44CA082620 (1), U01DK046472 (1)